<DOC>
	<DOC>NCT01249261</DOC>
	<brief_summary>The effects of stopping long-term (7 years) and short term (2 years) risedronate therapy on BMD (bone mineral density) and BTMs (bone turnover markers) will be summarized.</brief_summary>
	<brief_title>Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Postmenopausal women who sequentially completed studies RVE009093, RVE1996077, RVE1998080 Less than 60% compliant between drug start and month 21 Using bisphosphonates, glucocorticoids, anabolic steroids, vitamin D supplements, calcitrol, estrogen or estrogenrelated drugs, progestogen, depot injection &gt;10,000 IU vitamin D, investigational drug</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Postmenopausal Women</keyword>
	<keyword>Osteoporosis</keyword>
</DOC>